Private equity dealmakers are refilling deal pipelines, eyeing carveouts and pursuing add-ons like gangbusters despite market uncertainty, panelists said at a JPM session this week.
Why it matters: The LBO playbook of pre-COVID health care M&A isn't as applicable now, especially when debt is more expensive.
